Literature DB >> 30317115

The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus.

Qiong Wu1, Hua Wang2.   

Abstract

OBJECTIVE: To investigate the spatiotemporal expression of cannabinoid receptor type 2 (CB2R) in the hippocampus of pilocarpine-treated rats experiencing a status epilepticus (SE).
METHODS: A total of 112 male Sprague-Dawley rats at three weeks of age, weighing 43 g-68.5 g, were used for this study. Rats were randomly divided into a control group (n = 16) and an epilepsy a SE group. The epilepsy SE group was further divided into 6 sub-groups (2 h, 1, 3, 7, 14, and 21 days after status epilepticus (SE)). A SE model was induced with lithium chloride and pilocarpine by intraperitoneal injection. Hematoxylin-Eosin staining (H&E staining) and TdT-mediated dUTP nick end labeling (TUNEL staining) were used to observe neuronal necrosis and apoptosis pyroptosis in the hippocampus. Double-label immunofluorescence and Western blotting were used to detect the distribution and expression of CB2R in the rat hippocampus exposed to SE.
RESULTS: According to the Racine scale, nearly 15% of the pilocarpine-induced rats showed Racine stages 1 and 2 in the epilepsy group, almost 74% of the rats showed Racine stages 3 to 5, and 11% of the rats died in the SE or post SE. Morphologically, compared with control group, the number of neurons remarkably decreased while apoptotic pyroptotic neurons in number significantly increased in the CA1, CA3 and DG regions from 2 h to 3 days post SE by H&amp;E and TUNEL staining, respectively (p < 0.05). Double immunofluorescence staining revealed that CB2R was mainly expressed in the CA1, CA3 and DG neuronal regions of the hippocampus and the number of CB2R-positive neurons significantly increased within these regions post SE as compared with the control group, particularly in the DG region. Furthermore, the protein expression of CB2R began to be elevated from 2 h post SE (p < 0.05) and peaked at 1, 3 and 7 days (p < 0.01), respectively peaked at 1 day and high levels were maintained at 3 and 7 days (p < 0.01 for all of them). After that, the protein expression of CB2R gradually declined with by time interval.
CONCLUSIONS: We demonstrate that CB2R is expressed in hippocampal neurons and time-dependently expressed changed post SE, suggesting that the role of CB2R is mainly through hippocampal neurons at the early stage of pilocarpine-induced SE. CB2R may play a role at the early stage of pilocarpine-induced SE and its role is mainly through the hippocampal neurons.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabinoid receptor type 2; Hippocampal neurons; Pilocarpine; Status epilepticus

Mesh:

Substances:

Year:  2018        PMID: 30317115     DOI: 10.1016/j.eplepsyres.2018.10.002

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  9 in total

1.  Role of Modulation of Hippocampal Glucose Following Pilocarpine-Induced Status Epilepticus.

Authors:  Igor Santana de Melo; Yngrid Mickaelli Oliveira Dos Santos; Amanda Larissa Dias Pacheco; Maisa Araújo Costa; Vanessa de Oliveira Silva; Jucilene Freitas-Santos; Cibelle de Melo Bastos Cavalcante; Reginaldo Correia Silva-Filho; Ana Catarina Rezende Leite; Daniel Góes Leite Gitaí; Marcelo Duzzioni; Robinson Sabino-Silva; Alexandre Urban Borbely; Olagide Wagner de Castro
Journal:  Mol Neurobiol       Date:  2020-10-29       Impact factor: 5.590

2.  Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.

Authors:  Lindsey Shapiro; Jennifer C Wong; Andrew Escayg
Journal:  Epilepsia       Date:  2019-11-22       Impact factor: 5.864

3.  Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics.

Authors:  Ying Yu; Lexiao Li; Davis T Nguyen; Suni M Mustafa; Bob M Moore; Jianxiong Jiang
Journal:  Mol Neurobiol       Date:  2020-05-06       Impact factor: 5.590

4.  Changes in the expression of endothelial monocyte‑activating polypeptide II in the rat hippocampus following status epilepticus.

Authors:  Chun Li; Weining Ma; Yajuan Zhao; Hua Wang
Journal:  Int J Mol Med       Date:  2020-12-03       Impact factor: 4.101

5.  Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.

Authors:  Qing-Rong Liu; Ana Canseco-Alba; Ying Liang; Hiroki Ishiguro; Emmanuel S Onaivi
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

6.  CB2R orchestrates neuronal autophagy through regulation of the mTOR signaling pathway in the hippocampus of developing rats with status epilepticus.

Authors:  Qiong Wu; Miao Zhang; Xueyan Liu; Junmei Zhang; Hua Wang
Journal:  Int J Mol Med       Date:  2019-12-23       Impact factor: 4.101

Review 7.  Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy.

Authors:  Diogo M Lourenço; Leonor Ribeiro-Rodrigues; Ana M Sebastião; Maria J Diógenes; Sara Xapelli
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

Review 8.  Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases.

Authors:  Dhanush Haspula; Michelle A Clark
Journal:  Int J Mol Sci       Date:  2020-10-17       Impact factor: 5.923

Review 9.  The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models.

Authors:  Jon Egaña-Huguet; Edgar Soria-Gómez; Pedro Grandes
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.